期刊文献+

药物化学实验中引入新药创新模拟大奖赛的教学探讨 被引量:5

Innovative Reform of the Medicine Chemistry Experiment Teaching through Simulation Competition for New Drug Development
下载PDF
导出
摘要 探讨药物化学实验教学中如何培养学生组织协调和创新能力,介绍药物化学实验引入新药创新模拟大奖赛的教学方法。按照大奖赛形成制定大赛规程,学生为主体,自行制定实验方案,对方案进行答辩、点评和修改,按照实验方案进行实际操作,最后进行大奖赛答辩、评奖、表彰及总结工作。实践证明,大奖赛能激发学生学习兴趣,培养独立思考、开拓创新和组织协调能力,增强自信、提高协同创新与交流能力。 How to cultivate the student's potential of organization, coordination, and innovation in the medicine chemistry experiment. This paper introduces teaching methods which used a simulation competition for new drug development in our Medicine Chemistry Experiment. The rules and regulations are established according to the simulation competition. The students are required to design the protocol design, do experiment, test, analyze, and debate. Finally, the authors commend and summarize the process of the simulation competition, and awards to some outstanding students. This simulation competition can stimulate students' interest in thinking learning , develop , innovation, organizational skills and serf-confidence, and improve communication skills and independent collaborative innovation.
作者 徐德锋 刘燕
出处 《药学教育》 2013年第6期49-52,共4页 Pharmaceutical Education
关键词 药物化学实验 新药创新 大奖赛 实验教学 Medicinal Chemistry Experiment New Drug Innovation Simulation Competition Experimental teaching
  • 相关文献

参考文献5

二级参考文献25

  • 1陈洪渊.实验教学是造就创造型人才的摇篮[J].实验室研究与探索,2005,24(8):1-3. 被引量:86
  • 2李灵芝,崔颖,龚海英,张丽.药物化学实验教学中设立开放性实验的尝试[J].中国高等医学教育,2006(8):5-6. 被引量:25
  • 3PFEFFERKORN JA, CHOI C, SONG Y, et al. Design and synthesis of navel, conformationally restricted HMG-CoA reductase inhibitors [ J ]. Bioorg Med Chem Lett, 2007, 17 ( 16 ) : 4531 - 4537.
  • 4EVANS BE, RITTLE KE, BaCK MG, et al. Methods for drug discovery: development of potent, selective, orally effective chalecyctokinin antagonists [ J ]. J Med Chem, 1988, 31 ( 13 ) : 2235 - 2246.
  • 5SALEM EA, KENDIRCI M, HELLSTROM WJG, et al. Drug evaluation : Udenafil, a long-acting PDE5 inhibitor for erectile dynsfunction [ J ]. Curr Opin lnvestig Drugs, 2006, 7 (7) :661 - 669.
  • 6BOEHM HJ, FLOHR A, STAHL M. Scaffold hopping[J]. Drug Discov Today Technol, 2004, 1 (3) : 217 -224.
  • 7TSUJIHARA K, HONGU M, SAITO K, et al. Na^+ -glucose contransporter (SGLT) inhibitors as antidiabetic agenls. 4. Synthesis and pharmacological properties of 4'-dehydroxyphlorizin derivatives substituled on the B ring[J]. J Med Chem, 1999, 42 (26) : 5311 -5324.
  • 8KATSUNO K, FUJIMORI Y, TAKEMURA Y, el el. Scrgliflozin, a novel selective inhibitor of low-affinity sndium glucose cotransporter (SGLT2), validates the critical role of SGLT2 in renal glucose reabsorption and modulates plasma glucose level[ J ]. J Pharmacol Exp Ther, 2007, 320(1) :323 -330.
  • 9MENG W, ELLSWORTH BA, ALEXANDRA A, et al. Discovery of dapagliflozin: A polent, selective renal sodium-dependent glucose cotransporter 2 ( SGLT2 ) inhibitor for the treatment of type2 diabetes[J]. J Med Chem, 2008, 51(5) :1145-1149.
  • 10ROTHMAN RB, BAUMANN MH, SAVAGEJE, etal. Evidence for possible involvemenl of 5-HT (2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergie medications[J]. Circulation, 2000, 102(23): 2836-2841.

共引文献72

同被引文献31

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部